Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity Explore TARA-002's data in NMIBC treatment. Discover findings from three trials, including response rates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback